F&FFinancial Insights

Financial Metrics

CVS CVS HEALTH Corp
Range: 2016-01-01 to 2026-04-29
Export Quarterly CSV Export Annual CSV
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 43215000000.0 — USD 10-Q 2017-05-02
Quarterly 2016-06-30 43725000000.0 +1.2% USD 10-Q 2017-08-08
Quarterly 2016-09-30 44615000000.0 +2.0% USD 10-Q 2017-11-06
Quarterly 2017-03-31 44514000000.0 -0.2% USD 10-Q 2018-05-02
Quarterly 2017-06-30 45685000000.0 +2.6% USD 10-Q 2018-08-08
Quarterly 2017-09-30 46181000000.0 +1.1% USD 10-Q 2018-11-06
Quarterly 2018-03-31 45743000000.0 -0.9% USD 10-Q 2019-05-01
Quarterly 2018-06-30 46922000000.0 +2.6% USD 10-Q 2019-08-07
Quarterly 2018-09-30 47490000000.0 +1.2% USD 10-Q 2019-11-06
Quarterly 2019-03-31 61646000000.0 +29.8% USD 10-Q 2020-05-06
Quarterly 2019-06-30 63431000000.0 +2.9% USD 10-Q 2020-08-05
Quarterly 2019-09-30 64810000000.0 +2.2% USD 10-Q 2020-11-06
Quarterly 2020-03-31 66755000000.0 +3.0% USD 10-Q 2021-05-04
Quarterly 2020-06-30 65341000000.0 -2.1% USD 10-Q 2021-08-04
Quarterly 2020-09-30 67056000000.0 +2.6% USD 10-Q 2021-11-03
Quarterly 2021-03-31 69097000000.0 +3.0% USD 10-Q 2022-05-04
Quarterly 2021-06-30 72616000000.0 +5.1% USD 10-Q 2022-08-03
Quarterly 2021-09-30 73794000000.0 +1.6% USD 10-Q 2022-11-02
Quarterly 2022-03-31 76826000000.0 +4.1% USD 10-Q 2023-05-03
Quarterly 2022-06-30 80636000000.0 +5.0% USD 10-Q 2023-08-02
Quarterly 2022-09-30 81159000000.0 +0.6% USD 10-Q 2023-11-01
Quarterly 2023-03-31 85278000000.0 +5.1% USD 10-Q 2024-05-01
Quarterly 2023-06-30 88921000000.0 +4.3% USD 10-Q 2024-08-07
Quarterly 2023-09-30 89764000000.0 +0.9% USD 10-Q 2024-11-06
Quarterly 2024-03-31 88437000000.0 -1.5% USD 10-Q 2025-05-01
Quarterly 2024-06-30 91234000000.0 +3.2% USD 10-Q 2025-07-31
Quarterly 2024-09-30 95428000000.0 +4.6% USD 10-Q 2025-10-29
Quarterly 2025-03-31 94588000000.0 -0.9% USD 10-Q 2025-05-01
Quarterly 2025-06-30 98915000000.0 +4.6% USD 10-Q 2025-07-31
Quarterly 2025-09-30 102871000000.0 +4.0% USD 10-Q 2025-10-29
Annual 2016-12-31 177546000000.0 — USD 10-K 2019-02-28
Annual 2017-12-31 184786000000.0 +4.1% USD 10-K 2020-02-18
Annual 2018-12-31 194579000000.0 +5.3% USD 10-K 2021-02-16
Annual 2019-12-31 256776000000.0 +32.0% USD 10-K 2022-02-09
Annual 2020-12-31 268706000000.0 +4.6% USD 10-K 2023-02-08
Annual 2021-12-31 292111000000.0 +8.7% USD 10-K 2024-02-07
Annual 2022-12-31 322467000000.0 +10.4% USD 10-K 2025-02-12
Annual 2023-12-31 357776000000.0 +10.9% USD 10-K 2026-02-10
Annual 2024-12-31 372809000000.0 +4.2% USD 10-K 2026-02-10
Annual 2025-12-31 402067000000.0 +7.8% USD 10-K 2026-02-10

Gross Profit

Q: 9 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 6744000000.0 — USD 10-Q 2017-05-02
Quarterly 2016-06-30 7015000000.0 +4.0% USD 10-Q 2017-08-08
Quarterly 2016-09-30 7492000000.0 +6.8% USD 10-Q 2017-11-06
Quarterly 2017-03-31 6571000000.0 -12.3% USD 10-Q 2018-05-02
Quarterly 2017-06-30 6926000000.0 +5.4% USD 10-Q 2018-08-08
Quarterly 2017-09-30 7117000000.0 +2.8% USD 10-Q 2018-11-06
Quarterly 2018-03-31 6859000000.0 -3.6% USD 10-Q 2018-05-02
Quarterly 2018-06-30 7201000000.0 +5.0% USD 10-Q 2018-08-08
Quarterly 2018-09-30 7328000000.0 +1.8% USD 10-Q 2018-11-06
Annual 2016-12-31 7606000000.0 — USD 10-K 2018-02-14
Annual 2017-12-31 7904000000.0 +3.9% USD 10-K 2018-02-14

Operating Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 2185000000.0 — USD 10-Q 2017-05-02
Quarterly 2016-06-30 2357000000.0 +7.9% USD 10-Q 2017-08-08
Quarterly 2016-09-30 2824000000.0 +19.8% USD 10-Q 2017-11-06
Quarterly 2017-03-31 1793000000.0 -36.5% USD 10-Q 2018-05-02
Quarterly 2017-06-30 2117000000.0 +18.1% USD 10-Q 2018-08-08
Quarterly 2017-09-30 2499000000.0 +18.0% USD 10-Q 2018-11-06
Quarterly 2018-03-31 1996000000.0 -20.1% USD 10-Q 2019-05-01
Quarterly 2018-06-30 -1373000000.0 -168.8% USD 10-Q 2019-08-07
Quarterly 2018-09-30 2574000000.0 +287.5% USD 10-Q 2019-11-06
Quarterly 2019-03-31 2690000000.0 +4.5% USD 10-Q 2020-05-06
Quarterly 2019-06-30 3332000000.0 +23.9% USD 10-Q 2020-08-05
Quarterly 2019-09-30 2928000000.0 -12.1% USD 10-Q 2020-11-06
Quarterly 2020-03-31 3458000000.0 +18.1% USD 10-Q 2021-05-04
Quarterly 2020-06-30 4680000000.0 +35.3% USD 10-Q 2021-08-04
Quarterly 2020-09-30 3249000000.0 -30.6% USD 10-Q 2021-11-03
Quarterly 2021-03-31 3577000000.0 +10.1% USD 10-Q 2022-05-04
Quarterly 2021-06-30 4326000000.0 +20.9% USD 10-Q 2022-08-03
Quarterly 2021-09-30 3061000000.0 -29.2% USD 10-Q 2022-11-02
Quarterly 2022-03-31 3545000000.0 +15.8% USD 10-Q 2023-05-03
Quarterly 2022-06-30 4669000000.0 +31.7% USD 10-Q 2023-08-02
Quarterly 2022-09-30 -3919000000.0 -183.9% USD 10-Q 2023-11-01
Quarterly 2023-03-31 3446000000.0 +187.9% USD 10-Q 2024-05-01
Quarterly 2023-06-30 3234000000.0 -6.2% USD 10-Q 2024-08-07
Quarterly 2023-09-30 3690000000.0 +14.1% USD 10-Q 2024-11-06
Quarterly 2024-03-31 2271000000.0 -38.5% USD 10-Q 2025-05-01
Quarterly 2024-06-30 3045000000.0 +34.1% USD 10-Q 2025-07-31
Quarterly 2024-09-30 832000000.0 -72.7% USD 10-Q 2025-10-29
Quarterly 2025-03-31 3374000000.0 +305.5% USD 10-Q 2025-05-01
Quarterly 2025-06-30 2381000000.0 -29.4% USD 10-Q 2025-07-31
Quarterly 2025-09-30 -3207000000.0 -234.7% USD 10-Q 2025-10-29
Annual 2016-12-31 10386000000.0 — USD 10-K 2019-02-28
Annual 2017-12-31 9538000000.0 -8.2% USD 10-K 2020-02-18
Annual 2018-12-31 4021000000.0 -57.8% USD 10-K 2021-02-16
Annual 2019-12-31 11987000000.0 +198.1% USD 10-K 2022-02-09
Annual 2020-12-31 13911000000.0 +16.1% USD 10-K 2023-02-08
Annual 2021-12-31 13310000000.0 -4.3% USD 10-K 2024-02-07
Annual 2022-12-31 7954000000.0 -40.2% USD 10-K 2025-02-12
Annual 2023-12-31 13743000000.0 +72.8% USD 10-K 2026-02-10
Annual 2024-12-31 8516000000.0 -38.0% USD 10-K 2026-02-10
Annual 2025-12-31 4660000000.0 -45.3% USD 10-K 2026-02-10

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 1147000000.0 — USD 10-Q 2017-05-02
Quarterly 2016-06-30 924000000.0 -19.4% USD 10-Q 2017-08-08
Quarterly 2016-09-30 1541000000.0 +66.8% USD 10-Q 2017-11-06
Quarterly 2017-03-31 953000000.0 -38.2% USD 10-Q 2018-05-02
Quarterly 2017-06-30 1098000000.0 +15.2% USD 10-Q 2018-08-08
Quarterly 2017-09-30 1285000000.0 +17.0% USD 10-Q 2018-11-06
Quarterly 2018-03-31 998000000.0 -22.3% USD 10-Q 2019-05-01
Quarterly 2018-06-30 -2563000000.0 -356.8% USD 10-Q 2019-08-07
Quarterly 2018-09-30 1390000000.0 +154.2% USD 10-Q 2019-11-06
Quarterly 2019-03-31 1427000000.0 +2.7% USD 10-Q 2020-05-06
Quarterly 2019-06-30 1931000000.0 +35.3% USD 10-Q 2020-08-05
Quarterly 2019-09-30 1529000000.0 -20.8% USD 10-Q 2020-11-06
Quarterly 2020-03-31 2012000000.0 +31.6% USD 10-Q 2021-11-03
Quarterly 2020-06-30 2986000000.0 +48.4% USD 10-Q 2021-11-03
Quarterly 2020-09-30 1219000000.0 -59.2% USD 10-Q 2021-11-03
Quarterly 2021-03-31 2224000000.0 +82.4% USD 10-Q 2022-11-02
Quarterly 2021-06-30 2791000000.0 +25.5% USD 10-Q 2022-11-02
Quarterly 2021-09-30 1587000000.0 -43.1% USD 10-Q 2022-11-02
Quarterly 2022-03-31 2355000000.0 +48.4% USD 10-Q 2023-11-01
Quarterly 2022-06-30 3039000000.0 +29.0% USD 10-Q 2023-11-01
Quarterly 2022-09-30 -3399000000.0 -211.8% USD 10-Q 2023-11-01
Quarterly 2023-03-31 2142000000.0 +163.0% USD 10-Q 2024-11-06
Quarterly 2023-06-30 1914000000.0 -10.6% USD 10-Q 2024-11-06
Quarterly 2023-09-30 2265000000.0 +18.3% USD 10-Q 2024-11-06
Quarterly 2024-03-31 1124000000.0 -50.4% USD 10-Q 2025-10-29
Quarterly 2024-06-30 1768000000.0 +57.3% USD 10-Q 2025-10-29
Quarterly 2024-09-30 71000000.0 -96.0% USD 10-Q 2025-10-29
Quarterly 2025-03-31 1782000000.0 +2409.9% USD 10-Q 2025-10-29
Quarterly 2025-06-30 1013000000.0 -43.2% USD 10-Q 2025-10-29
Quarterly 2025-09-30 -3990000000.0 -493.9% USD 10-Q 2025-10-29
Annual 2016-12-31 5319000000.0 — USD 10-K 2019-02-28
Annual 2017-12-31 6623000000.0 +24.5% USD 10-K 2020-02-18
Annual 2018-12-31 -596000000.0 -109.0% USD 10-K 2021-02-16
Annual 2019-12-31 6631000000.0 +1212.6% USD 10-K 2022-02-09
Annual 2020-12-31 7192000000.0 +8.5% USD 10-K 2023-02-08
Annual 2021-12-31 7989000000.0 +11.1% USD 10-K 2024-02-07
Annual 2022-12-31 4327000000.0 -45.8% USD 10-K 2025-02-12
Annual 2023-12-31 8368000000.0 +93.4% USD 10-K 2026-02-10
Annual 2024-12-31 4586000000.0 -45.2% USD 10-K 2026-02-10
Annual 2025-12-31 1728000000.0 -62.3% USD 10-K 2026-02-10

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 1.04 — USD/shares 10-Q 2017-05-02
Quarterly 2016-06-30 0.86 -17.3% USD/shares 10-Q 2017-08-08
Quarterly 2016-09-30 1.44 +67.4% USD/shares 10-Q 2017-11-06
Quarterly 2017-03-31 0.92 -36.1% USD/shares 10-Q 2018-05-02
Quarterly 2017-06-30 1.07 +16.3% USD/shares 10-Q 2018-08-08
Quarterly 2017-09-30 1.26 +17.8% USD/shares 10-Q 2018-11-06
Quarterly 2018-03-31 0.98 -22.2% USD/shares 10-Q 2019-05-01
Quarterly 2018-06-30 -2.52 -357.1% USD/shares 10-Q 2019-08-07
Quarterly 2018-09-30 1.36 +154.0% USD/shares 10-Q 2019-11-06
Quarterly 2019-03-31 1.09 -19.9% USD/shares 10-Q 2020-05-06
Quarterly 2019-06-30 1.49 +36.7% USD/shares 10-Q 2020-08-05
Quarterly 2019-09-30 1.17 -21.5% USD/shares 10-Q 2020-11-06
Quarterly 2020-03-31 1.54 +31.6% USD/shares 10-Q 2021-05-04
Quarterly 2020-06-30 2.27 +47.4% USD/shares 10-Q 2021-08-04
Quarterly 2020-09-30 0.93 -59.0% USD/shares 10-Q 2021-11-03
Quarterly 2021-03-31 1.69 +81.7% USD/shares 10-Q 2022-05-04
Quarterly 2021-06-30 2.11 +24.9% USD/shares 10-Q 2022-08-03
Quarterly 2021-09-30 1.21 -42.7% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 1.79 +47.9% USD/shares 10-Q 2023-05-03
Quarterly 2022-06-30 2.31 +29.1% USD/shares 10-Q 2023-08-02
Quarterly 2022-09-30 -2.59 -212.1% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 1.66 +164.1% USD/shares 10-Q 2024-05-01
Quarterly 2023-06-30 1.48 -10.8% USD/shares 10-Q 2024-08-07
Quarterly 2023-09-30 1.76 +18.9% USD/shares 10-Q 2024-11-06
Quarterly 2024-03-31 0.88 -50.0% USD/shares 10-Q 2025-05-01
Quarterly 2024-06-30 1.41 +60.2% USD/shares 10-Q 2025-07-31
Quarterly 2024-09-30 0.07 -95.0% USD/shares 10-Q 2025-10-29
Quarterly 2025-03-31 1.41 +1914.3% USD/shares 10-Q 2025-05-01
Quarterly 2025-06-30 0.81 -42.6% USD/shares 10-Q 2025-07-31
Quarterly 2025-09-30 -3.13 -486.4% USD/shares 10-Q 2025-10-29
Annual 2016-12-31 4.93 — USD/shares 10-K 2019-02-28
Annual 2017-12-31 6.47 +31.2% USD/shares 10-K 2020-02-18
Annual 2018-12-31 -0.57 -108.8% USD/shares 10-K 2021-02-16
Annual 2019-12-31 5.1 +994.7% USD/shares 10-K 2022-02-09
Annual 2020-12-31 5.48 +7.5% USD/shares 10-K 2023-02-08
Annual 2021-12-31 6.07 +10.8% USD/shares 10-K 2024-02-07
Annual 2022-12-31 3.29 -45.8% USD/shares 10-K 2025-02-12
Annual 2023-12-31 6.49 +97.3% USD/shares 10-K 2026-02-10
Annual 2024-12-31 3.67 -43.5% USD/shares 10-K 2026-02-10
Annual 2025-12-31 1.4 -61.9% USD/shares 10-K 2026-02-10

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 1.04 — USD/shares 10-Q 2017-05-02
Quarterly 2016-06-30 0.86 -17.3% USD/shares 10-Q 2017-08-08
Quarterly 2016-09-30 1.43 +66.3% USD/shares 10-Q 2017-11-06
Quarterly 2017-03-31 0.92 -35.7% USD/shares 10-Q 2018-05-02
Quarterly 2017-06-30 1.07 +16.3% USD/shares 10-Q 2018-08-08
Quarterly 2017-09-30 1.26 +17.8% USD/shares 10-Q 2018-11-06
Quarterly 2018-03-31 0.98 -22.2% USD/shares 10-Q 2019-05-01
Quarterly 2018-06-30 -2.52 -357.1% USD/shares 10-Q 2019-08-07
Quarterly 2018-09-30 1.36 +154.0% USD/shares 10-Q 2019-11-06
Quarterly 2019-03-31 1.09 -19.9% USD/shares 10-Q 2020-05-06
Quarterly 2019-06-30 1.49 +36.7% USD/shares 10-Q 2020-08-05
Quarterly 2019-09-30 1.17 -21.5% USD/shares 10-Q 2020-11-06
Quarterly 2020-03-31 1.53 +30.8% USD/shares 10-Q 2021-05-04
Quarterly 2020-06-30 2.26 +47.7% USD/shares 10-Q 2021-08-04
Quarterly 2020-09-30 0.93 -58.8% USD/shares 10-Q 2021-11-03
Quarterly 2021-03-31 1.68 +80.6% USD/shares 10-Q 2022-05-04
Quarterly 2021-06-30 2.1 +25.0% USD/shares 10-Q 2022-08-03
Quarterly 2021-09-30 1.2 -42.9% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 1.77 +47.5% USD/shares 10-Q 2023-05-03
Quarterly 2022-06-30 2.29 +29.4% USD/shares 10-Q 2023-08-02
Quarterly 2022-09-30 -2.59 -213.1% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 1.65 +163.7% USD/shares 10-Q 2024-05-01
Quarterly 2023-06-30 1.48 -10.3% USD/shares 10-Q 2024-08-07
Quarterly 2023-09-30 1.75 +18.2% USD/shares 10-Q 2024-11-06
Quarterly 2024-03-31 0.88 -49.7% USD/shares 10-Q 2025-05-01
Quarterly 2024-06-30 1.41 +60.2% USD/shares 10-Q 2025-07-31
Quarterly 2024-09-30 0.07 -95.0% USD/shares 10-Q 2025-10-29
Quarterly 2025-03-31 1.41 +1914.3% USD/shares 10-Q 2025-05-01
Quarterly 2025-06-30 0.8 -43.3% USD/shares 10-Q 2025-07-31
Quarterly 2025-09-30 -3.13 -491.2% USD/shares 10-Q 2025-10-29
Annual 2016-12-31 4.9 — USD/shares 10-K 2019-02-28
Annual 2017-12-31 6.44 +31.4% USD/shares 10-K 2020-02-18
Annual 2018-12-31 -0.57 -108.9% USD/shares 10-K 2021-02-16
Annual 2019-12-31 5.08 +991.2% USD/shares 10-K 2022-02-09
Annual 2020-12-31 5.46 +7.5% USD/shares 10-K 2023-02-08
Annual 2021-12-31 6.02 +10.3% USD/shares 10-K 2024-02-07
Annual 2022-12-31 3.26 -45.8% USD/shares 10-K 2025-02-12
Annual 2023-12-31 6.47 +98.5% USD/shares 10-K 2026-02-10
Annual 2024-12-31 3.66 -43.4% USD/shares 10-K 2026-02-10
Annual 2025-12-31 1.39 -62.0% USD/shares 10-K 2026-02-10

8-K Material Event Details

83 filings · 163 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

325 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-04-01 Shah Prem S EVP and Group President Other disposed transaction
F
 Common Stock 1,484 $72.49 $107,575 64,356
2026-03-31 Shah Prem S EVP and Group President Equity grant / award
A · derivative
 Stock Option 161,676 $71.82 $11,611,570 161,676
2026-03-31 Shah Prem S EVP and Group President Equity grant / award
A
 Common Stock (Restricted) 25,062 $71.82 $1,799,953 62,852
2026-03-19 Gallina John E Dir Equity grant / award
A
 Common Stock 582 $71.86 $41,823 582
2026-02-28 Khichi Samrat S. EVP, CPO and General Counsel Other disposed transaction
F
 Common Stock 7,886 $79.60 $627,726 29,775
2026-01-01 Shah Prem S EVP and Group President Other disposed transaction
F
 Common Stock 247 $80.13 $19,792 61,509
2025-12-01 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock (Restricted) 220 $79.10 $17,402 24,401
2025-11-30 Mandadi Tilak EVP, Chief Exp & Tech Officer Other disposed transaction
F
 Common Stock 6,575 $80.36 $528,367 74,085
2025-11-20 Shulman Douglas H. Dir Equity grant / award
A
 Common Stock 1,652 $76.04 $125,618 5,929
2025-08-31 Shah Prem S EVP and Group President Other disposed transaction
F
 Common Stock 6,995 $73.15 $511,684 60,632
2025-08-20 Finucane Anne A. Dir Open-market sell
S
 Common Stock 7,500 $71.02 $532,650 22,156
2025-06-05 SANSONE GUY P Dir Open-market buy
P
 Common Stock 1,570 $63.70 $100,009 12,007
2025-05-31 Newman Brian EVP, Chief Financial Officer Equity grant / award
A · derivative
 Stock Option 94,786 $0.00 $0 94,786
2025-05-31 Newman Brian EVP, Chief Financial Officer Equity grant / award
A
 Common Stock (RSUs) 21,861 $64.04 $1,399,978 21,861
2025-05-15 Shulman Douglas H. Dir Equity grant / award
A
 Common Stock 2,077 $60.47 $125,596 4,277
2025-05-06 ROBBINS LARRY — Open-market sell
S
 Common Stock 150,000 $66.67 $10,000,710 8,196,799
2025-05-05 ROBBINS LARRY — Open-market sell
S
 Common Stock 96,999 $67.99 $6,595,272 8,346,799
2025-05-05 ROBBINS LARRY — Open-market sell
S
 Common Stock 1,226,933 $67.37 $82,654,673 8,443,798
2025-05-02 ROBBINS LARRY — Open-market sell
S
 Common Stock 373,776 $69.66 $26,035,592 9,670,731
2025-05-02 ROBBINS LARRY — Open-market sell
S
 Common Stock 222,556 $68.38 $15,218,980 10,044,507
2025-05-02 ROBBINS LARRY — Open-market sell
S
 Common Stock 1,679,736 $67.39 $113,190,186 10,267,063
2025-04-01 Shah Prem S EVP and Group President Equity grant / award
A · derivative
 Stock Option 112,289 $67.98 $7,633,406 112,289
2025-04-01 Shah Prem S EVP and Group President Equity grant / award
A
 Common Stock (Restricted) 26,478 $67.98 $1,799,974 58,166
2025-04-01 Shah Prem S EVP and Group President Other disposed transaction
F
 Common Stock 1,308 $67.98 $88,918 47,251
2025-04-01 Joyner J. David President and CEO Equity grant / award
A
 Common Stock (RSUs) 53,324 $0.00 $0 82,515
2025-03-17 Shah Prem S EVP and Group President Exercise / conversion
M · derivative
 Stock Option 846 $0.00 $0 0
2025-03-17 Shah Prem S EVP and Group President Exercise / conversion
M
 Common Stock 846 $62.21 $52,630 43,190
2025-03-05 Clark James David SVP, Cont & Chief Acct Officer Exercise / conversion
M · derivative
 Stock Option 7,513 $0.00 $0 0
2025-03-05 Clark James David SVP, Cont & Chief Acct Officer Open-market sell
S
 Common Stock 7,513 $66.35 $498,488 8,394
2025-03-05 Clark James David SVP, Cont & Chief Acct Officer Exercise / conversion
M
 Common Stock 7,513 $62.21 $467,384 15,907
2025-02-28 Khichi Samrat S. EVP, CPO and General Counsel Other disposed transaction
F
 Common Stock 5,604 $65.72 $368,295 20,106
2025-02-18 Mahoney Michael F Dir Open-market buy
P
 Common Stock (By Trust) 30,000 $66.70 $2,001,000 39,356
2025-01-23 Nelson Steven H EVP and President, Aetna Open-market buy
P
 Common Stock (By Trust) 24 $53.70 $1,289 24
2024-12-05 Finucane Anne A. Dir Equity grant / award
G
 Common Stock 2,665 $56.86 $151,532 4,567
2024-11-30 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 86 $59.85 $5,147 8,394
2024-11-30 Joyner J. David President and CEO Equity grant / award
A · derivative
 Premium Stock Appreciation Right 492,537 $71.82 $35,374,007 492,537
2024-11-30 Joyner J. David President and CEO Equity grant / award
A · derivative
 Premium Stock Option 1,000,000 $71.82 $71,820,000 1,000,000
2024-11-21 ROBBINS LARRY Dir Equity grant / award
A · derivative
 Deferred Stock Units 2,933 $57.10 $167,500 2,933
2024-10-23 CAPOZZI HEIDI B EVP and Chief People Officer Open-market buy
P
 Common Stock 35 $56.85 $1,990 85
2024-10-02 CAPOZZI HEIDI B EVP and Chief People Officer Open-market buy
P
 Common Stock 10 $62.24 $622 50
2024-09-09 CAPOZZI HEIDI B EVP and Chief People Officer Open-market buy
P
 Common Stock 35 $56.47 $1,976 40
2024-08-31 Mandadi Tilak EVP, Chief Technology Officer Other disposed transaction
F
 Common Stock 13,097 $57.24 $749,672 40,414
2024-05-16 SCHAPIRO MARY L Dir Equity grant / award
A · derivative
 Share Credits 2,912 $57.52 $167,500 21,017
2024-05-02 LUDWIG EDWARD J Dir Open-market buy
P
 Common Stock 1,000 $53.88 $53,879 21,630
2024-04-01 Clark James David SVP, Cont & Chief Acct Officer Equity grant / award
A
 Common Stock (Restricted) 10,683 $79.56 $849,939 15,109
2024-04-01 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 1,112 $79.56 $88,471 8,480
2024-04-01 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 1,892 $79.56 $150,528 9,592
2024-02-28 Joyner J. David EVP&President-PharmacyServices Other disposed transaction
F
 Common Stock 1,970 $75.19 $148,124 40,681
2024-02-26 Shah Prem S EVP and Pres-Pharm, Consumer W Other disposed transaction
F
 Common Stock 261 $76.43 $19,948 43,185
2024-02-16 Shah Prem S EVP and Pres-Pharm, Consumer W Open-market sell
S
 Common Stock 29,473 $76.95 $2,267,947 39,765
2024-02-12 Chaguturu Sreekanth K EVP and Chief Medical Officer Equity grant / award
A
 Common Stock 1,926 $0.00 $0 8,645
2023-12-14 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock (Restricted) 122 $68.48 $8,355 8,760
2023-12-07 Finucane Anne A. Dir Equity grant / award
G
 Common Stock 3,450 $74.28 $256,266 7,232
2023-11-30 Kane Brian A EVP/President, Aetna Equity grant / award
A · derivative
 Stock Option 77,017 $67.95 $5,233,305 77,017
2023-11-15 SCHAPIRO MARY L Dir Equity grant / award
A · derivative
 Share Credits 1,817 $69.13 $125,625 17,735
2023-11-03 LUDWIG EDWARD J Dir Open-market buy
P
 Common Stock 2,000 $70.47 $140,930 20,630
2023-10-02 KIRBY J SCOTT Dir Equity grant / award
A
 Common Stock 299 $69.82 $20,876 299
2023-08-31 Shah Prem S EVP and Co-President of Retail Other disposed transaction
F
 Common Stock 3,508 $65.17 $228,616 50,988
2023-08-03 Clark James David SVP, Cont & Chief Acct Officer Open-market sell
S
 Common Stock 23,128 $74.94 $1,733,212 4,698
2023-08-03 Clark James David SVP, Cont & Chief Acct Officer Open-market sell
S
 Common Stock 2,631 $74.79 $196,792 27,826
2023-05-18 MILLON JEAN PIERRE Dir Equity grant / award
A
 Common Stock 1,437 $69.31 $99,598 1,437
2023-05-03 Lynch Karen S President and CEO Open-market buy
P
 Common Stock (By Trust) 14,000 $69.75 $976,567 431,392
2023-04-01 Shah Prem S EVP and Co-President of Retail Equity grant / award
A · derivative
 Stock Option 89,073 $74.31 $6,619,015 89,073
2023-04-01 Shah Prem S EVP and Co-President of Retail Other disposed transaction
F
 Common Stock 3,221 $74.31 $239,353 49,364
2023-02-28 Khichi Samrat S. EVP, CPO and General Counsel Equity grant / award
A
 Common Stock (Restricted) 47,881 $83.54 $3,999,979 47,881
2023-02-27 Shah Prem S EVP and Co-President of Retail Other disposed transaction
F
 Common Stock 226 $85.77 $19,384 44,403
2023-02-02 PELUSO MICHELLE A EVP and Co-President of Retail Equity grant / award
A
 Common Stock 192,554 $0.00 $0 207,465
2022-12-31 Moriarty Thomas M EVP & General Counsel Other disposed transaction
F
 Common Stock 292,856 $93.19 $27,291,251 315,273
2022-12-15 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 36,490 $0.00 $0 0
2022-12-15 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 100,976 $0.00 $0 24,248
2022-12-15 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 36,490 $98.24 $3,584,869 608,129
2022-12-15 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 36,490 $62.21 $2,270,043 644,619
2022-12-15 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 100,976 $98.40 $9,936,311 608,129
2022-12-15 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 100,976 $78.05 $7,881,177 709,105
2022-12-01 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 153 $101.65 $15,552 26,177
2022-11-29 Chaguturu Sreekanth K EVP and Chief Medical Officer Other disposed transaction
F
 Common Stock 442 $100.88 $44,589 2,897
2022-11-18 Finucane Anne A. Dir Equity grant / award
G
 Common Stock 800 $97.35 $77,880 28,964
2022-11-17 WELDON WILLIAM C Dir Equity grant / award
A · derivative
 Share Credits 1,764 $94.93 $167,500 41,834
2022-09-12 Balser Jeffrey R. Dir Equity grant / award
A
 Common Stock 406 $0.00 $0 624
2022-08-31 Chaguturu Sreekanth K EVP and Chief Medical Officer Equity grant / award
A
 Common Stock (RSU) 12,735 $0.00 $0 12,735
2022-08-04 Lotvin Alan EVP&President-PharmacyServices Exercise / conversion
M · derivative
 Stock Option 22,541 $0.00 $0 0
2022-08-04 Lotvin Alan EVP&President-PharmacyServices Open-market sell
S
 Common Stock 22,541 $104.00 $2,344,264 109,183
2022-08-04 Lotvin Alan EVP&President-PharmacyServices Exercise / conversion
M
 Common Stock 22,541 $62.21 $1,402,276 131,724
2022-08-03 Lotvin Alan EVP&President-PharmacyServices Exercise / conversion
M · derivative
 Stock Option 50,501 $0.00 $0 20,201
2022-08-03 Lotvin Alan EVP&President-PharmacyServices Exercise / conversion
M · derivative
 Stock Option 70,398 $0.00 $0 70,399
2022-08-03 Lotvin Alan EVP&President-PharmacyServices Open-market sell
S
 Common Stock 50,501 $98.00 $4,949,098 109,183
2022-08-03 Lotvin Alan EVP&President-PharmacyServices Exercise / conversion
M
 Common Stock 50,501 $54.19 $2,736,649 159,684
2022-08-03 Lotvin Alan EVP&President-PharmacyServices Open-market sell
S
 Common Stock 70,398 $98.00 $6,899,004 109,183
2022-08-03 Lotvin Alan EVP&President-PharmacyServices Exercise / conversion
M
 Common Stock 70,398 $58.34 $4,107,019 179,581
2022-06-28 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 38,873 $0.00 $0 116,622
2022-06-28 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 50,502 $0.00 $0 50,502
2022-06-28 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 49,279 $0.00 $0 98,558
2022-06-28 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 38,873 $95.00 $3,692,935 626,273
2022-06-28 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 38,873 $74.30 $2,888,264 665,146
2022-06-28 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 50,502 $95.00 $4,797,690 626,273
2022-06-28 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 50,502 $54.19 $2,736,703 676,775
2022-06-28 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 49,279 $95.00 $4,681,505 626,273
2022-06-28 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 49,279 $58.35 $2,875,430 675,552
2022-05-31 Chaguturu Sreekanth K EVP and Chief Medical Officer Equity grant / award
A
 Common Stock (RSU) 12,919 $0.00 $0 12,919
2022-05-31 Chaguturu Sreekanth K EVP and Chief Medical Officer Equity grant / award
A
 Common Stock (RSU) 0 $0.00 — 0
2022-05-11 DORMAN DAVID W Dir Equity grant / award
A
 Common Stock 51 $97.99 $4,997 109,875
2022-04-08 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M · derivative
 Stock Option 4,103 $0.00 $0 28,723
2022-04-08 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M · derivative
 Stock Option 5,719 $0.00 $0 28,596
2022-04-08 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M · derivative
 Stock Option 3,157 $0.00 $0 9,469
2022-04-08 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M · derivative
 Stock Option 845 $0.00 $0 846
2022-04-08 Shah Prem S EVP and Co-President of Retail Open-market sell
S
 Common Stock 3,130 $105.00 $328,650 43,453
2022-04-08 Shah Prem S EVP and Co-President of Retail Open-market sell
S
 Common Stock 4,103 $105.00 $430,815 46,583
2022-04-08 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M
 Common Stock 4,103 $74.30 $304,853 50,686
2022-04-08 Shah Prem S EVP and Co-President of Retail Open-market sell
S
 Common Stock 5,719 $105.00 $600,495 46,583
2022-04-08 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M
 Common Stock 5,719 $58.34 $333,646 52,302
2022-04-08 Shah Prem S EVP and Co-President of Retail Open-market sell
S
 Common Stock 3,157 $105.00 $331,485 46,583
2022-04-08 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M
 Common Stock 3,157 $54.19 $171,078 49,740
2022-04-08 Shah Prem S EVP and Co-President of Retail Open-market sell
S
 Common Stock 845 $105.00 $88,725 46,583
2022-04-08 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M
 Common Stock 845 $62.21 $52,567 47,428
2022-04-05 Finke Daniel P EVP/Pres, Health Care Benefits Open-market sell
S
 Common Stock 5,941 $100.00 $594,100 32,150
2022-04-04 Finke Daniel P EVP/Pres, Health Care Benefits Exercise / conversion
M · derivative
 Stock Option 27,166 $0.00 $0 27,166
2022-04-04 Finke Daniel P EVP/Pres, Health Care Benefits Exercise / conversion
M · derivative
 Stock Option 16,161 $0.00 $0 16,161
2022-04-04 Finke Daniel P EVP/Pres, Health Care Benefits Open-market sell
S
 Common Stock 12,032 $100.13 $1,204,764 38,091
2022-04-04 Finke Daniel P EVP/Pres, Health Care Benefits Open-market sell
S
 Common Stock 27,166 $100.13 $2,720,132 50,123
2022-04-04 Finke Daniel P EVP/Pres, Health Care Benefits Exercise / conversion
M
 Common Stock 27,166 $58.34 $1,584,864 77,289
2022-04-04 Finke Daniel P EVP/Pres, Health Care Benefits Open-market sell
S
 Common Stock 16,161 $100.13 $1,618,201 50,123
2022-04-04 Finke Daniel P EVP/Pres, Health Care Benefits Exercise / conversion
M
 Common Stock 16,161 $54.19 $875,765 66,284
2022-04-01 PELUSO MICHELLE A EVP and Co-President of Retail Equity grant / award
A · derivative
 Stock Option 57,172 $101.09 $5,779,517 57,172
2022-03-30 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M · derivative
 Stock Option 5,346 $0.00 $0 0
2022-03-30 Shah Prem S EVP and Co-President of Retail Open-market sell
S
 Common Stock 5,346 $104.70 $559,726 59,071
2022-03-30 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M
 Common Stock 5,346 $102.26 $546,682 64,417
2022-03-17 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M · derivative
 Stock Option 2,935 $0.00 $0 2,935
2022-03-17 Shah Prem S EVP and Co-President of Retail Open-market sell
S
 Common Stock 2,935 $106.65 $313,018 59,071
2022-03-17 Shah Prem S EVP and Co-President of Retail Exercise / conversion
M
 Common Stock 2,935 $104.82 $307,647 62,006
2022-03-17 Shah Prem S EVP and Co-President of Retail Open-market sell
S
 Common Stock 1,689 $106.65 $180,132 59,071
2022-03-15 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 51,361 $0.00 $0 0
2022-03-15 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 51,361 $102.26 $5,252,176 888,112
2022-03-15 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 51,361 $105.00 $5,392,905 836,751
2022-02-28 Shah Prem S EVP and Co-President of Retail Other disposed transaction
F
 Common Stock 141 $103.65 $14,615 60,760
2022-02-28 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 253 $103.65 $26,223 26,668
2022-02-28 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 183 $103.65 $18,968 26,334
2022-02-26 Shah Prem S EVP and Co-President of Retail Other disposed transaction
F
 Common Stock 226 $104.30 $23,572 59,394
2022-02-21 Shah Prem S EVP and Co-President of Retail Equity grant / award
A
 Common Stock 47,640 $0.00 $0 59,620
2022-02-10 LUDWIG EDWARD J Dir Open-market buy
P
 Common Stock 1,000 $105.90 $105,904 18,334
2022-02-03 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M · derivative
 Stock Option 47,937 $0.00 $0 0
2022-02-03 Brennan Troyen A EVP and Chief Medical Officer Open-market sell
S
 Common Stock 47,937 $110.00 $5,273,070 138,246
2022-02-03 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M
 Common Stock 47,937 $102.26 $4,902,038 186,183
2022-02-01 Lotvin Alan EVP&President-PharmacyServices Exercise / conversion
M · derivative
 Stock Option 21,386 $0.00 $0 0
2022-02-01 Lotvin Alan EVP&President-PharmacyServices Open-market sell
S
 Common Stock 21,386 $106.50 $2,277,566 61,341
2022-02-01 Lotvin Alan EVP&President-PharmacyServices Exercise / conversion
M
 Common Stock 21,386 $102.26 $2,186,932 82,727
2022-01-28 Clark James David SVP, Cont & Chief Acct Officer Exercise / conversion
M · derivative
 Stock Option 6,059 $0.00 $0 0
2022-01-28 Clark James David SVP, Cont & Chief Acct Officer Open-market sell
S
 Common Stock 6,059 $109.00 $660,431 17,497
2022-01-28 Clark James David SVP, Cont & Chief Acct Officer Exercise / conversion
M
 Common Stock 6,059 $102.26 $619,593 23,556
2022-01-27 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M · derivative
 Stock Option 68,482 $0.00 $0 0
2022-01-27 Roberts Jonathan C EVP & Chief Operating Officer Open-market sell
S
 Common Stock 68,482 $107.50 $7,361,815 107,115
2022-01-27 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M
 Common Stock 68,482 $102.26 $7,002,969 175,597
2021-12-27 Lotvin Alan EVP&President-PharmacyServices Other disposed transaction
F
 Common Stock (restricted) 200 $88.78 $17,756 5,827
2021-12-01 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock (restricted) 68 $88.78 $6,037 16,921
2021-12-01 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock (restricted) 266 $88.78 $23,615 16,723
2021-11-28 Lynch Karen S President and CEO Other disposed transaction
F
 Common Stock 14,121 $91.52 $1,292,354 69,114
2021-11-17 BROWN C DAVID II Dir Equity grant / award
A · derivative
 Share Credits 1,779 $92.73 $165,000 68,107
2021-11-03 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M · derivative
 Stock Option 108,870 $0.00 $0 0
2021-11-03 Roberts Jonathan C EVP & Chief Operating Officer Open-market sell
S
 Common Stock 108,870 $95.00 $10,342,650 107,115
2021-11-03 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M
 Common Stock 108,870 $45.93 $5,000,399 215,985
2021-11-01 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M · derivative
 Stock Option 28,159 $0.00 $0 84,478
2021-11-01 Brennan Troyen A EVP and Chief Medical Officer Open-market sell
S
 Common Stock 28,159 $90.00 $2,534,310 138,246
2021-11-01 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M
 Common Stock 28,159 $58.34 $1,642,796 166,405
2021-10-26 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M · derivative
 Stock Option 80,802 $0.00 $0 80,803
2021-10-26 Brennan Troyen A EVP and Chief Medical Officer Open-market sell
S
 Common Stock 80,802 $88.00 $7,110,576 138,246
2021-10-26 Brennan Troyen A EVP and Chief Medical Officer Open-market sell
S
 Common Stock 1,955 $88.00 $172,040 219,048
2021-10-26 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M
 Common Stock 80,802 $54.19 $4,378,660 221,003
2021-09-02 Brennan Troyen A EVP and Chief Medical Officer Open-market sell
S
 Common Stock 2,625 $87.00 $228,375 140,201
2021-08-05 LUDWIG EDWARD J Dir Open-market buy
P
 Common Stock 3,000 $79.55 $238,635 17,334
2021-06-28 Lotvin Alan EVP&President-PharmacyServices Open-market sell
S
 Common Stock 2,781 $83.67 $232,686 61,048
2021-06-15 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M · derivative
 Stock Option 65,681 $0.00 $0 21,894
2021-06-15 Brennan Troyen A EVP and Chief Medical Officer Open-market sell
S
 Common Stock 67,552 $86.00 $5,809,472 142,826
2021-06-15 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M
 Common Stock 65,681 $62.21 $4,086,015 210,378
2021-06-07 Finke Daniel P EVP/Pres, Health Care Benefits Exercise / conversion
M · derivative
 Stock Option 32,320 $0.00 $0 32,322
2021-06-07 Finke Daniel P EVP/Pres, Health Care Benefits Open-market sell
S
 Common Stock 37,594 $86.60 $3,255,640 23,310
2021-06-07 Finke Daniel P EVP/Pres, Health Care Benefits Exercise / conversion
M
 Common Stock 32,320 $54.19 $1,751,421 60,904
2021-05-31 MERLO LARRY J Dir Other disposed transaction
F
 Common Stock 634 $86.44 $54,803 632,313
2021-05-28 GUERTIN SHAWN M EVP & Chief Financial Officer Equity grant / award
A · derivative
 Stock Option 97,562 $86.44 $8,433,259 97,562
2021-05-28 GUERTIN SHAWN M EVP & Chief Financial Officer Equity grant / award
A
 Common Stock (restricted) 34,706 $86.44 $2,999,987 34,706
2021-05-13 WHITE TONY L Dir Equity grant / award
A
 Common Stock 1,446 $84.27 $121,854 36,500
2021-05-10 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 109,469 $0.00 $0 36,490
2021-05-10 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 109,469 $86.00 $9,414,334 0
2021-05-10 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 109,469 $62.21 $6,810,066 109,469
2021-05-07 Brennan Troyen A EVP and Chief Medical Officer Open-market sell
S
 Common Stock 9,477 $84.00 $796,068 144,697
2021-05-04 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 49,279 $0.00 $0 147,837
2021-05-04 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 49,279 $58.34 $2,874,937 49,279
2021-04-21 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 101,003 $0.00 $0 101,004
2021-04-21 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 2,420 $77.00 $186,340 0
2021-04-21 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 101,003 $77.00 $7,777,231 2,420
2021-04-21 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 101,003 $54.19 $5,473,353 103,423
2021-04-03 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 480 $74.30 $35,664 17,497
2021-04-01 Roberts Jonathan C EVP & Chief Operating Officer Equity grant / award
A · derivative
 Stock Option 172,772 $74.30 $12,836,960 172,772
2021-04-01 Roberts Jonathan C EVP & Chief Operating Officer Other disposed transaction
F
 Common Stock 79,714 $74.30 $5,922,750 96,761
2021-04-01 Montgomery Neela EVP and Pres., Pharmacy/Retail Equity grant / award
A · derivative
 Stock Option 86,386 $74.30 $6,418,480 86,386
2021-03-31 Clark James David SVP, Cont & Chief Acct Officer Exercise / conversion
M · derivative
 Stock Option 5,350 $0.00 $0 0
2021-03-31 Clark James David SVP, Cont & Chief Acct Officer Open-market sell
S
 Common Stock 5,350 $76.00 $406,600 7,244
2021-03-31 Clark James David SVP, Cont & Chief Acct Officer Exercise / conversion
M
 Common Stock 5,350 $74.29 $397,452 12,594
2021-03-29 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M · derivative
 Stock Option 62,943 $0.00 $0 0
2021-03-29 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 62,943 $76.15 $4,793,109 0
2021-03-29 Moriarty Thomas M EVP & General Counsel Exercise / conversion
M
 Common Stock 62,943 $74.29 $4,676,035 62,943
2021-03-26 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M · derivative
 Stock Option 73,433 $0.00 $0 0
2021-03-26 Roberts Jonathan C EVP & Chief Operating Officer Open-market sell
S
 Common Stock 73,433 $74.49 $5,470,024 664
2021-03-26 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M
 Common Stock 73,433 $74.29 $5,455,338 74,097
2021-03-19 Moriarty Thomas M EVP & General Counsel Open-market sell
S
 Common Stock 49,211 $74.15 $3,648,996 18,226
2021-03-16 Boratto Eva C EVP & CFO Exercise / conversion
M · derivative
 Stock Option 18,882 $0.00 $0 0
2021-03-16 Boratto Eva C EVP & CFO Open-market sell
S
 Common Stock 18,882 $74.68 $1,410,108 71,082
2021-03-16 Boratto Eva C EVP & CFO Exercise / conversion
M
 Common Stock 18,882 $74.29 $1,402,744 89,964
2021-03-02 Finke Daniel P EVP/Pres, Health Care Benefits Other disposed transaction
F
 Common Stock 2,413 $68.94 $166,352 15,073
2021-02-28 Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL Other disposed transaction
F
 Common Stock 572 $0.00 $0 25,657
2021-02-26 Havanec Laurie P. EVP and Chief People Officer Equity grant / award
A
 Common Stock (restricted) 44,033 $68.13 $2,999,968 44,033
2021-02-17 LUDWIG EDWARD J Dir Open-market buy
P
 Common Stock 3,000 $72.00 $216,000 14,334
2021-02-01 Roberts Jonathan C EVP & Chief Operating Officer Equity grant / award
A
 Common Stock 175,811 $0.00 $0 176,475
2021-01-19 MERLO LARRY J President and CEO Exercise / conversion
M · derivative
 Stock Option 64,350 $0.00 $0 271,347
2021-01-19 MERLO LARRY J President and CEO Open-market sell
S
 Common Stock 62,893 $77.00 $4,842,761 523,329
2021-01-19 MERLO LARRY J President and CEO Exercise / conversion
M
 Common Stock 64,350 $74.29 $4,780,562 586,222
2021-01-12 Bisaccia Lisa EVP and Chief HR Officer Exercise / conversion
M · derivative
 Stock Option 25,177 $0.00 $0 0
2021-01-12 Bisaccia Lisa EVP and Chief HR Officer Open-market sell
S
 Common Stock 25,177 $77.00 $1,938,629 46,588
2021-01-12 Bisaccia Lisa EVP and Chief HR Officer Exercise / conversion
M
 Common Stock 25,177 $74.29 $1,870,399 71,765
2021-01-08 Lotvin Alan EVP and President-CVS Caremark Exercise / conversion
M · derivative
 Stock Option 15,736 $0.00 $0 0
2021-01-08 Lotvin Alan EVP and President-CVS Caremark Exercise / conversion
M · derivative
 Stock Option 10,100 $0.00 $0 70,702
2021-01-08 Lotvin Alan EVP and President-CVS Caremark Open-market sell
S
 Common Stock 25,836 $75.00 $1,937,700 8,369
2021-01-08 Lotvin Alan EVP and President-CVS Caremark Exercise / conversion
M
 Common Stock 15,736 $74.29 $1,169,027 34,205
2021-01-08 Lotvin Alan EVP and President-CVS Caremark Exercise / conversion
M
 Common Stock 10,100 $54.19 $547,319 18,469
2020-12-02 Mayhew Jonathan E. EVP - Transformation Other disposed transaction
F
 Common Stock 926 $69.63 $64,477 6,855
2020-11-30 Montgomery Neela EVP and Pres., Pharmacy/Retail Equity grant / award
A
 Common Stock (restricted) 29,502 $67.79 $1,999,941 29,502
2020-11-18 DEPARLE NANCY ANN Dir Equity grant / award
A
 Common Stock 1,836 $66.35 $121,819 20,600
2020-11-13 Lotvin Alan EVP and President-CVS Caremark Open-market sell
S
 Common Stock 7,138 $70.00 $499,660 8,023
2020-11-10 Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL Exercise / conversion
M · derivative
 Stock Option 21,460 $0.00 $0 0
2020-11-10 Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL Open-market sell
S
 Common Stock 21,460 $70.00 $1,502,200 25,001
2020-11-10 Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL Exercise / conversion
M
 Common Stock 21,460 $34.96 $750,242 46,461
2020-05-26 Mayhew Jonathan E. EVP - Transformation Open-market sell
S
 Common Stock 10,556 $65.00 $686,140 4,732
2020-05-14 WHITE TONY L Dir Equity grant / award
A
 Common Stock 1,955 $62.31 $121,816 33,218
2020-05-11 Lotvin Alan EVP and President-CVS Caremark Open-market buy
P
 Common Stock 5,000 $63.13 $315,675 15,161
2020-04-28 Clark James David SVP, Cont & Chief Acct Officer Open-market sell
S
 Common Stock 6,234 $65.00 $405,210 4,817
2020-04-03 Brennan Troyen A EVP and Chief Medical Officer Other disposed transaction
F
 Common Stock 2,179 $55.72 $121,414 104,904
2020-04-01 Clark James David SVP, Cont & Chief Acct Officer Equity grant / award
A · derivative
 Stock Option 17,157 $58.34 $1,000,939 17,157
2020-04-01 Clark James David SVP, Cont & Chief Acct Officer Equity grant / award
A
 Common Stock (restricted) 7,713 $58.34 $449,976 20,204
2020-04-01 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 681 $58.34 $39,730 11,321
2020-04-01 Mayhew Jonathan E. EVP, Chief Transformation Off Equity grant / award
A · derivative
 Stock Option 28,159 $0.00 $0 28,159
2020-03-30 Clark James David SVP, Cont & Chief Acct Officer Exercise / conversion
M · derivative
 Stock Option 3,030 $0.00 $0 0
2020-03-30 Clark James David SVP, Cont & Chief Acct Officer Open-market sell
S
 Common Stock 3,030 $60.00 $181,800 9,760
2020-03-30 Clark James David SVP, Cont & Chief Acct Officer Exercise / conversion
M
 Common Stock 3,030 $54.53 $165,226 12,790
2020-02-28 Rice Derica W EVP & President, CVS Caremark Other disposed transaction
F
 Common Stock 8,079 $59.18 $478,115 26,827
2020-02-28 Rice Derica W EVP & President, CVS Caremark Equity grant / award
A
 Common Stock 21,943 $59.18 $1,298,587 34,906
2020-02-27 Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL Other disposed transaction
F
 Common Stock 844 $59.33 $50,075 20,339
2020-02-18 Lynch Karen S EVP & Pres, Aetna Bus Unit Other disposed transaction
F
 Common Stock 14,215 $0.00 $0 78,966
2020-01-15 MERLO LARRY J President and CEO Exercise / conversion
M · derivative
 Stock Option 314,713 $0.00 $0 0
2020-01-15 MERLO LARRY J President and CEO Open-market sell
S
 Common Stock 266,476 $74.79 $19,929,740 437,021
2020-01-15 MERLO LARRY J President and CEO Exercise / conversion
M
 Common Stock 314,713 $54.53 $17,161,300 703,497
2020-01-08 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M · derivative
 Stock Option 68,844 $0.00 $0 0
2020-01-08 Roberts Jonathan C EVP & Chief Operating Officer Open-market sell
S
 Common Stock 57,563 $72.63 $4,180,801 45,045
2020-01-08 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M
 Common Stock 68,844 $54.53 $3,754,063 102,608
2019-12-02 Lynch Karen S EVP & Pres, Aetna Bus Unit Other disposed transaction
F
 Common Stock 12,778 $75.55 $965,378 57,235
2019-11-20 WHITE TONY L Dir Equity grant / award
A
 Common Stock 1,551 $74.92 $116,201 31,263
2019-11-18 Lynch Karen S EVP & Pres, Aetna Bus Unit Open-market sell
S
 Common Stock 80,143 $75.00 $6,010,725 41,831
2019-11-04 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M · derivative
 Stock Option 23,604 $0.00 $0 0
2019-11-04 Brennan Troyen A EVP and Chief Medical Officer Open-market sell
S
 Common Stock 23,604 $68.00 $1,605,072 84,317
2019-11-04 Brennan Troyen A EVP and Chief Medical Officer Exercise / conversion
M
 Common Stock 23,604 $54.53 $1,287,126 107,921
2019-09-30 Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL Exercise / conversion
M · derivative
 Stock Option 17,703 $0.00 $0 0
2019-09-30 Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL Open-market sell
S
 Common Stock 17,703 $63.00 $1,115,289 18,460
2019-09-30 Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL Exercise / conversion
M
 Common Stock 17,703 $54.53 $965,345 36,163
2019-09-12 Boratto Eva C EVP & CFO Exercise / conversion
M · derivative
 Stock Option 8,852 $0.00 $0 0
2019-09-12 Boratto Eva C EVP & CFO Open-market sell
S
 Common Stock 8,130 $65.00 $528,450 47,143
2019-09-12 Boratto Eva C EVP & CFO Exercise / conversion
M
 Common Stock 8,852 $54.53 $482,700 55,273
2019-05-31 Rice Derica W EVP & President, CVS Caremark Other disposed transaction
F
 Common Stock 3,576 $52.37 $187,275 12,442
2019-05-16 WHITE TONY L Dir Equity grant / award
A
 Common Stock 2,222 $52.30 $116,211 29,712
2019-04-01 Clark James David SVP, Cont & Chief Acct Officer Equity grant / award
A · derivative
 Stock Option 24,240 $54.19 $1,313,566 24,240
2019-04-01 Clark James David SVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 253 $54.19 $13,710 9,135
2019-04-01 Clark James David SVP, Cont & Chief Acct Officer Equity grant / award
A
 Common Stock (restricted) 5,536 $54.19 $299,996 13,793
2019-04-01 Flum Joshua Matthew EVP, Ent. Strategy & Digital Equity grant / award
A · derivative
 Stock Option 60,602 $54.19 $3,284,022 60,602
2019-04-01 Flum Joshua Matthew EVP, Ent. Strategy & Digital Other disposed transaction
F
 Common Stock 742 $54.19 $40,209 18,460
2019-03-11 BROWN C DAVID II Dir Open-market buy
P
 Common Stock 10,000 $53.18 $531,800 111,252
2019-03-08 LUDWIG EDWARD J Dir Open-market buy
P
 Common Stock 2,000 $52.80 $105,600 7,378
2019-03-01 AGUIRRE FERNANDO Dir Open-market buy
P
 Common Stock 3,410 $58.29 $198,769 14,322
2019-02-28 Bisaccia Lisa EVP and Chief HR Officer Other disposed transaction
F
 Common Stock 3,015 $57.83 $174,357 25,023
2019-02-28 Bisaccia Lisa EVP and Chief HR Officer Equity grant / award
A
 Common Stock 6,952 $57.83 $402,034 28,038
2019-02-28 Flum Joshua Matthew EVP, Ent. Strategy & Digital Equity grant / award
A
 Common Stock (restricted) 2,297 $57.83 $132,836 17,768
2019-02-28 Flum Joshua Matthew EVP, Ent. Strategy & Digital Equity grant / award
A
 Common Stock 1,268 $57.83 $73,328 16,214
2019-02-28 Flum Joshua Matthew EVP, Ent. Strategy & Digital Other disposed transaction
F
 Common Stock 990 $57.83 $57,252 14,946
2019-02-19 Lynch Karen S EVP & Pres, Aetna Bus Unit Other disposed transaction
F
 Common Stock 36,617 $69.88 $2,558,796 121,974
2019-02-01 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M · derivative
 Stock Option 77,639 $0.00 $0 0
2019-02-01 Roberts Jonathan C EVP & Chief Operating Officer Open-market sell
S
 Common Stock 77,639 $64.54 $5,010,821 33,764
2019-02-01 Roberts Jonathan C EVP & Chief Operating Officer Exercise / conversion
M
 Common Stock 77,639 $45.07 $3,499,190 111,403
2019-02-01 MERLO LARRY J President and CEO Exercise / conversion
M · derivative
 Stock Option 166,368 $0.00 $0 0
2019-02-01 MERLO LARRY J President and CEO Open-market sell
S
 Common Stock 166,368 $64.51 $10,732,400 330,209
2019-02-01 MERLO LARRY J President and CEO Exercise / conversion
M
 Common Stock 166,368 $45.07 $7,498,206 496,577
2019-01-08 MERLO LARRY J President and CEO Exercise / conversion
M · derivative
 Stock Option 166,368 $0.00 $0 166,368
2019-01-08 MERLO LARRY J President and CEO Open-market sell
S
 Common Stock 166,368 $69.04 $11,486,047 330,209
2019-01-08 MERLO LARRY J President and CEO Exercise / conversion
M
 Common Stock 166,368 $45.07 $7,498,206 496,577
2018-12-28 Bertolini Mark T Dir Equity grant / award
G
 Common Stock 655,982 $0.00 $0 10,000
2018-12-20 Bertolini Mark T Dir Other acquired transaction
J
 Common Stock 12,534 $67.26 $843,081 665,982
2018-12-20 Bertolini Mark T Dir Other acquired transaction
J
 Common Stock 112,808 $67.26 $7,587,861 653,448
2018-12-20 Bertolini Mark T Dir Other acquired transaction
J
 Common Stock 217,802 $67.26 $14,650,125 540,640
2018-12-20 Bertolini Mark T Dir Other acquired transaction
J
 Common Stock 90,127 $67.26 $6,062,257 322,838
2018-12-20 Bertolini Mark T Dir Other acquired transaction
J
 Common Stock 89,726 $67.26 $6,035,285 232,711
2018-12-02 Lynch Karen S EVP & Pres, Aetna Bus Unit Other disposed transaction
F
 Common Stock 13,060 $79.52 $1,038,531 77,869
2018-11-29 Denton David M EVP and CFO Open-market sell
S
 Common Stock 25,159 $80.13 $2,015,991 403
2018-11-28 AGUIRRE FERNANDO Dir Equity grant / award
A
 Common Stock 1,308 $80.27 $104,993 10,912
2018-11-28 AGUIRRE FERNANDO Dir Equity grant / award
A
 Common Stock 9,604 — — 9,604
2018-11-14 Brennan Troyen A EVP and Chief Medical Officer Open-market sell
S
 Common Stock 14,229 $82.00 $1,166,778 70,494
2018-11-07 WHITE TONY L Dir Equity grant / award
A
 Common Stock 1,332 $78.77 $104,922 27,490
2018-09-17 Boratto Eva C EVP, Cont & Chief Acct Officer Exercise / conversion
M · derivative
 Stock Option 13,311 $0.00 $0 0
2018-09-17 Boratto Eva C EVP, Cont & Chief Acct Officer Open-market sell
S
 Common Stock 13,311 $77.16 $1,027,077 41,851
2018-09-17 Boratto Eva C EVP, Cont & Chief Acct Officer Exercise / conversion
M
 Common Stock 13,311 $45.07 $599,927 55,162
2018-08-27 Hourican Kevin EVP & President, CVS Pharmacy Exercise / conversion
M · derivative
 Stock Option 4,426 $0.00 $0 0
2018-08-27 Hourican Kevin EVP & President, CVS Pharmacy Open-market sell
S
 Common Stock 8,564 $75.00 $642,300 3,571
2018-08-27 Hourican Kevin EVP & President, CVS Pharmacy Exercise / conversion
M
 Common Stock 4,426 $54.53 $241,350 12,135
2018-06-04 WHITE TONY L Dir Equity grant / award
A
 Common Stock 1,638 $64.10 $104,996 26,158
2018-05-04 DORMAN DAVID W Dir Open-market buy
P
 Common Stock 24,300 $62.22 $1,511,868 104,638
2018-04-01 Brennan Troyen A EVP and Chief Medical Officer Equity grant / award
A · derivative
 Stock Option 87,575 $62.21 $5,448,041 87,575
2018-04-01 Brennan Troyen A EVP and Chief Medical Officer Other disposed transaction
F
 Common Stock 4,047 $62.21 $251,764 84,723
2018-02-28 Boratto Eva C EVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 275 $67.73 $18,626 39,935
2018-02-28 Boratto Eva C EVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 242 $67.73 $16,391 40,490
2018-02-28 Boratto Eva C EVP, Cont & Chief Acct Officer Equity grant / award
A
 Common Stock 797 $67.73 $53,981 40,732
2018-02-28 Denton David M EVP and CFO Other disposed transaction
J
 Common Stock 1,851 $67.73 $125,368 20,252
2018-02-27 Boratto Eva C EVP, Cont & Chief Acct Officer Other disposed transaction
F
 Common Stock 197 $68.25 $13,445 39,277
2018-02-20 Denton David M EVP and CFO Other disposed transaction
J · derivative
 Stock Option 10,869 $0.00 $0 89,310
2018-02-20 Denton David M EVP and CFO Other disposed transaction
J · derivative
 Stock Option 22,716 $0.00 $0 48,980
2018-02-20 Denton David M EVP and CFO Other disposed transaction
J · derivative
 Stock Option 25,540 $0.00 $0 34,382
2018-02-20 Denton David M EVP and CFO Other disposed transaction
J · derivative
 Stock Option 30,325 $0.00 $0 32,618
2018-02-20 Denton David M EVP and CFO Other disposed transaction
J
 Common Stock 18,057 $0.00 $0 18,401
2018-02-20 Denton David M EVP and CFO Other disposed transaction
J
 Common Stock (restricted) 38,836 $0.00 $0 114,041
2018-02-16 Foulkes Helena EVP & President-CVS Pharmacy Exercise / conversion
M · derivative
 Stock Option 19,965 $0.00 $0 0
2018-02-16 Foulkes Helena EVP & President-CVS Pharmacy Open-market sell
S
 Common Stock 19,965 $71.04 $1,418,314 45,107
2018-02-16 Foulkes Helena EVP & President-CVS Pharmacy Exercise / conversion
M
 Common Stock 19,965 $45.07 $899,823 65,072
2017-12-21 Bisaccia Lisa EVP and Chief HR Officer Open-market sell
S
 Common Stock 29,445 $75.00 $2,208,375 15,556

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
21
Material Event Filings (8-K) — 12 months
10

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.